Zhejiang, China

Hairong Luo

This inventor holds 3 USPTO granted patents, plus 1 CIPO patent and 3 EPO patents. Top assignees: Zhejiang Hisun Pharmaceutical Co., Ltd., Shanghai Institute of Pharmaceutical Industry. Active years: 2014-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hairong Luo. Retrieved from https://idiyas.com/inventor/hairong-luo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


 

Average Co-Inventor Count = 9.2

ph-index = 2

Forward Citations = 8(Granted Patents)


Location History:

  • Zhejiang, CN (2014 - 2016)
  • Taizhou, CN (2017)

Company Filing History:


Years Active: 2014-2017

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Hairong Luo: Innovator in Pharmaceutical Chemistry

Introduction

Hairong Luo is a prominent inventor based in Zhejiang, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel drug formulations. With a total of 3 patents, his work has garnered attention for its innovative approaches and practical applications.

Latest Patents

One of Hairong Luo's latest patents is focused on the crystal form of dabigatran etexilate mesylate and its preparation method and use. This invention introduces novel crystal forms M and N, which exhibit unique X-Ray powder diffractogram characteristics. The crystal form M has peaks at 5.7±0.2°, 6.2±0.2°, 11.2±0.2°, 12.4±0.2°, 18.2±0.2°, 21.4±0.2°, 21.8±0.2°, and 23.6±0.2°. In contrast, crystal form N shows peaks at 6.0±0.2°, 11.8±0.2°, 18.2±0.2°, 21.6±0.2°, 24.4±0.2°, 27.7±0.2°, and 29.7±0.2°. These crystal forms are noted for their excellent properties in leaching time, biological release, chemical stability, and processing adaptability. Another significant patent involves a method for preparing a linezolid intermediate. This method offers a new approach to synthesizing a methyl substitute of a linezolid intermediate with a short process route, low cost, easy operation, and high yield, making it suitable for large-scale industrial production.

Career Highlights

Hairong Luo has worked with notable companies in the pharmaceutical industry, including Zhejiang Hisun Pharmaceutical Co., Ltd. and the Shanghai Institute of Pharmaceutical Industry. His experience in these organizations has allowed him to refine his skills and contribute to various innovative projects.

Collaborations

Some of his notable coworkers include Jian Chai and Hua Bai. Their collaborative efforts have further advanced the research and development of pharmaceutical innovations.

Conclusion

Hairong Luo's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor in the industry. His innovative approaches

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…